LB Pharmaceuticals Inc
lbpharma.us
Actively hiring
Health Care
Neurology & CNS Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Press enter to begin your search Close Search About LB-102 Leveraging a Proven Mechanism with Data-Driven Approach to Bolster Development for a Broad Range of Indications.
News
LB Pharmaceuticals to Participate in Upcoming September Investor Events
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (
Read more
Report
LB Pharmaceuticals Reports Q2 2026 Results, Advances LB-102 Timeline and Pipeline Expansion LBRX Stock News
LB Pharmaceuticals accelerated data readout for LB-102 in schizophrenia to 2027 and plans expansion into other neuropsychiatric indications.Quiver AI SummaryLB Pharmaceuticals Inc. has announced an accelerated timeline for the topline data readout from it
Read more
Report
LB Pharmaceuticals Inc (LBRX) stock price, news, quote and history - Yahoo Finance
Find the latest LB Pharmaceuticals Inc (LBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Read more
Report
LB Pharmaceuticals Inc (LBRX) Stock Price, News, Quote & History - Yahoo Finance
Find the latest LB Pharmaceuticals Inc (LBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Read more
Report
LB Pharmaceuticals Inc (LBRX) stock price, news, quote and history - Yahoo Finance
Find the latest LB Pharmaceuticals Inc (LBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Read more
Report
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (
Read more
Report
LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia
Robust 359 patient trial met primary endpoint with statistically significant reduction in PANSS total score at all dose levels compared to placebo ...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
Contact Us
Suite #1025, New York, NY 10119